Trader Bruker - BRKR CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Conditions de trading
| Écart | 0.14 | ||||||||
|
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.025457% | ||||||||
|
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | 0.003235% | ||||||||
| Durée des frais en overnight | 21:00 (UTC) | ||||||||
| Quantité minimale négociée | 1 | ||||||||
| Devise | USD | ||||||||
| Marge | 20% | ||||||||
| Bourse | United States of America | ||||||||
| Commission sur la négociation | 0% |
*Information provided by Capital.com
Bruker Corp ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Chiffres clés
| Fermeture précédente* | 62.52 |
| Ouvert* | 61.98 |
| Variation sur 1 an* | -1.59% |
| Fourchette du jour* | 61.8 - 62.86 |
| Fourchette sur 52 semaines | 48.42-84.84 |
| Volume moyen (10 jours) | 840.36K |
| Volume moyen (3 mois) | 18.14M |
| Capitalisation boursière | 10.41B |
| Ratio C/B | 33.78 |
| Actions en circulation | 146.73M |
| Revenu | 2.62B |
| EPS | 2.10 |
| Dividende (rendement en %) | 0.28193 |
| Bêta | 1.16 |
| Prochaine date de publication des résultats | Aug 1, 2023 |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Clôture | Change | Change (%) | Ouverture | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 62.88 | 0.68 | 1.09% | 62.20 | 63.00 | 61.54 |
| Jun 28, 2022 | 62.52 | -1.52 | -2.37% | 64.04 | 64.97 | 62.31 |
| Jun 27, 2022 | 63.77 | -0.38 | -0.59% | 64.15 | 64.49 | 63.03 |
| Jun 24, 2022 | 64.11 | -1.45 | -2.21% | 65.56 | 65.61 | 63.90 |
| Jun 23, 2022 | 64.81 | 3.46 | 5.64% | 61.35 | 65.02 | 61.35 |
| Jun 22, 2022 | 61.10 | 1.18 | 1.97% | 59.92 | 61.86 | 59.79 |
| Jun 21, 2022 | 60.59 | 0.35 | 0.58% | 60.24 | 61.37 | 59.80 |
| Jun 17, 2022 | 59.19 | -0.19 | -0.32% | 59.38 | 61.24 | 59.17 |
| Jun 16, 2022 | 59.33 | 1.11 | 1.91% | 58.22 | 60.02 | 58.22 |
| Jun 15, 2022 | 61.16 | 0.91 | 1.51% | 60.25 | 61.95 | 60.02 |
| Jun 14, 2022 | 60.12 | 0.51 | 0.86% | 59.61 | 60.49 | 58.34 |
| Jun 13, 2022 | 59.71 | -0.06 | -0.10% | 59.77 | 60.15 | 58.90 |
| Jun 10, 2022 | 61.64 | -0.44 | -0.71% | 62.08 | 62.62 | 61.22 |
| Jun 9, 2022 | 63.52 | 1.76 | 2.85% | 61.76 | 64.42 | 61.76 |
| Jun 8, 2022 | 64.27 | 1.73 | 2.77% | 62.54 | 64.69 | 62.54 |
| Jun 7, 2022 | 63.91 | 1.33 | 2.13% | 62.58 | 64.22 | 62.28 |
| Jun 6, 2022 | 63.14 | -0.15 | -0.24% | 63.29 | 63.98 | 62.63 |
| Jun 3, 2022 | 63.22 | 1.22 | 1.97% | 62.00 | 64.14 | 62.00 |
| Jun 2, 2022 | 64.59 | 3.30 | 5.38% | 61.29 | 64.72 | 60.95 |
| Jun 1, 2022 | 61.26 | -1.12 | -1.80% | 62.38 | 63.54 | 60.48 |
Bruker Events
| Heure (UTC) (UTC) | Pays | Événement |
|---|---|---|
| Wednesday, June 7, 2023 | ||
| Heure (UTC) (UTC) 14:00 | Pays US
| Événement Bruker Corp Annual Shareholders Meeting Bruker Corp Annual Shareholders MeetingForecast -Previous - |
| Friday, June 9, 2023 | ||
| Heure (UTC) (UTC) 13:00 | Pays US
| Événement Bruker Corp at Jefferies Healthcare Conference Bruker Corp at Jefferies Healthcare ConferenceForecast -Previous - |
| Thursday, June 15, 2023 | ||
| Heure (UTC) (UTC) 15:00 | Pays US
| Événement Bruker Corp To Host Investor Day Bruker Corp To Host Investor DayForecast -Previous - |
| Tuesday, August 1, 2023 | ||
| Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q2 2023 Bruker Corp Earnings Release Q2 2023 Bruker Corp Earnings ReleaseForecast -Previous - |
| Wednesday, November 1, 2023 | ||
| Heure (UTC) (UTC) 12:30 | Pays US
| Événement Q3 2023 Bruker Corp Earnings Release Q3 2023 Bruker Corp Earnings ReleaseForecast -Previous - |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenu total | 2530.7 | 2417.9 | 1987.5 | 2072.6 | 1895.6 |
| Revenu | 2530.7 | 2417.9 | 1987.5 | 2072.6 | 1895.6 |
| Coût des recettes, total | 1224.1 | 1208.3 | 1047.7 | 1077.3 | 995.6 |
| Résultat brut | 1306.6 | 1209.6 | 939.8 | 995.3 | 900 |
| Total des frais d'exploitation | 2098 | 2004.6 | 1739.2 | 1771.7 | 1633.2 |
| Total des frais de vente/Généraux/Admin | 609.8 | 562.3 | 474.5 | 502.3 | 449.2 |
| Recherche et développement | 235.9 | 220.8 | 198 | 187.7 | 173.4 |
| Charges (revenus) inhabituelles | 27.4 | 13.2 | 19 | 4.4 | 15 |
| Produits d'exploitation | 432.7 | 413.3 | 248.3 | 300.9 | 262.4 |
| Produits (charges) d'intérêts, nets Hors exploitation | -17.8 | -17.5 | -19.2 | -18 | -14.4 |
| Autres, nets | -1 | -2.2 | -3.3 | -2.5 | -3.3 |
| Résultat net avant impôts | 413.9 | 393.6 | 225.8 | 280.4 | 244.7 |
| Résultat net après impôts | 297.5 | 280.6 | 161.4 | 198 | 181 |
| Intérêts minoritaires | -1.9 | -3.5 | -3.6 | -0.8 | -1.3 |
| Résultat net avant éléments extra | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Résultat net | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Résultat net dilué | 296.6 | 277.1 | 157.8 | 197.2 | 179.7 |
| Moyenne pondérée des actions diluées | 149.4 | 152.9 | 154.6 | 156.6 | 157.2 |
| BPA dilué hors éléments extraordinaires | 1.98527 | 1.8123 | 1.0207 | 1.25926 | 1.14313 |
| Dividends per Share - Common Stock Primary Issue | 0.2 | 0.16 | 0.16 | 0.16 | 0.16 |
| BPA dilué normalisé | 2.1171 | 1.88969 | 1.12981 | 1.303 | 1.21371 |
| Total des éléments extraordinaires | |||||
| Other Operating Expenses, Total | 0.8 | ||||
| Equity In Affiliates | 1 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Revenu total | 685.3 | 708.4 | 638.9 | 588.4 | 595 |
| Revenu | 685.3 | 708.4 | 638.9 | 588.4 | 595 |
| Coût des recettes, total | 325.4 | 342.8 | 303.8 | 288.9 | 288.6 |
| Résultat brut | 359.9 | 365.6 | 335.1 | 299.5 | 306.4 |
| Total des frais d'exploitation | 569.5 | 577.4 | 507.6 | 514.5 | 498.5 |
| Total des frais de vente/Généraux/Admin | 162.7 | 167.1 | 144.8 | 152.2 | 146.1 |
| Recherche et développement | 69 | 63.5 | 56.2 | 59.6 | 56.6 |
| Charges (revenus) inhabituelles | 10.8 | 5.7 | 1.6 | 13.6 | 6.9 |
| Other Operating Expenses, Total | 1.6 | -1.7 | 1.2 | 0.2 | 0.3 |
| Produits d'exploitation | 115.8 | 131 | 131.3 | 73.9 | 96.5 |
| Produits (charges) d'intérêts, nets Hors exploitation | -9.1 | -10 | -2 | -4.3 | -2.5 |
| Résultat net avant impôts | 106.6 | 121 | 129.3 | 69.6 | 94 |
| Résultat net après impôts | 76.7 | 97.6 | 88.1 | 49.7 | 62.1 |
| Intérêts minoritaires | -0.9 | -0.9 | -0.3 | -0.2 | -0.5 |
| Résultat net avant éléments extra | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Résultat net | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Résultat net dilué | 76.5 | 97.4 | 88.1 | 49.5 | 61.6 |
| Moyenne pondérée des actions diluées | 147.6 | 147.9 | 148.6 | 149.8 | 151.4 |
| BPA dilué hors éléments extraordinaires | 0.51829 | 0.65855 | 0.59287 | 0.33044 | 0.40687 |
| Dividends per Share - Common Stock Primary Issue | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| BPA dilué normalisé | 0.57094 | 0.68964 | 0.6002 | 0.39527 | 0.43698 |
| Equity In Affiliates | 0.7 | 0.7 | 0.3 | ||
| Autres, nets | -0.1 |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total de l'actif à court terme | 2113.2 | 2471.8 | 1925 | 1796.3 | 1304.3 |
| Espèces et placements à court terme | 645.5 | 1168.2 | 731.8 | 684.9 | 322.4 |
| Trésorerie et équivalents | 645.5 | 1068.2 | 681.8 | 678.3 | 322.4 |
| Investissements à court terme | 0 | 100 | 50 | 6.6 | 0 |
| Total des créances, nettes | 472.7 | 416.9 | 335.3 | 362.2 | 357.2 |
| Accounts Receivable - Trade, Net | 472.7 | 416.9 | 335.3 | 362.2 | 357.2 |
| Total Inventory | 800.1 | 710.1 | 692.3 | 577.2 | 509.6 |
| Other Current Assets, Total | 194.9 | 176.6 | 165.6 | 172 | 115.1 |
| Total Assets | 3611.8 | 3650 | 3049 | 2771.5 | 2128.6 |
| Property/Plant/Equipment, Total - Net | 538.2 | 466 | 462.9 | 371.7 | 270.6 |
| Property/Plant/Equipment, Total - Gross | 984.9 | 901.1 | 895.4 | 797.3 | 692.4 |
| Accumulated Depreciation, Total | -446.7 | -435.1 | -432.5 | -425.6 | -421.8 |
| Goodwill, Net | 457.6 | 339.5 | 320.4 | 293 | 275.7 |
| Intangibles, Net | 270.9 | 211.8 | 229.1 | 233.2 | 218.7 |
| Other Long Term Assets, Total | 231.9 | 160.9 | 111.6 | 77.3 | 59.3 |
| Total Current Liabilities | 914.3 | 938.5 | 791.9 | 645.6 | 599.3 |
| Accounts Payable | 178.4 | 147.4 | 134.6 | 118.4 | 104.5 |
| Accrued Expenses | 195.1 | 186.1 | 181.4 | 164.4 | |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 18.7 | 112.4 | 2.2 | 0.5 | 18.5 |
| Other Current Liabilities, Total | 522.1 | 678.7 | 469 | 345.3 | 311.9 |
| Total Liabilities | 2498 | 2579.5 | 2087.8 | 1864.7 | 1232 |
| Total Long Term Debt | 1200.5 | 1221.8 | 842.3 | 812.8 | 322.6 |
| Long Term Debt | 1188.8 | 1219.2 | 839.7 | 811.7 | 322.6 |
| Deferred Income Tax | 62.3 | 46 | 43.1 | 48.8 | 51.1 |
| Minority Interest | 18 | 14.3 | 13.1 | 31.4 | 31.1 |
| Other Liabilities, Total | 302.9 | 358.9 | 397.4 | 326.1 | 227.9 |
| Total Equity | 1113.8 | 1070.5 | 961.2 | 906.8 | 896.6 |
| Common Stock | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| Additional Paid-In Capital | 256.3 | 237.8 | 216.3 | 199.7 | 176.9 |
| Retained Earnings (Accumulated Deficit) | 1926 | 1659.5 | 1406.5 | 1274.7 | 1102.5 |
| Treasury Stock - Common | -1085 | -820.3 | -667 | -543.8 | -401.5 |
| Other Equity, Total | 14.8 | -8.2 | 3.7 | -25.5 | 17 |
| Total Liabilities & Shareholders’ Equity | 3611.8 | 3650 | 3049 | 2771.5 | 2128.6 |
| Total Common Shares Outstanding | 147.023 | 150.754 | 151.987 | 154.156 | 156.609 |
| Capital Lease Obligations | 11.7 | 2.6 | 2.6 | 1.1 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total de l'actif à court terme | 2133 | 2113.2 | 2036.6 | 2087.5 | 2250.8 |
| Espèces et placements à court terme | 597.9 | 645.5 | 626.2 | 723 | 916.1 |
| Trésorerie et équivalents | 597.9 | 645.5 | 626.2 | 723 | 816.1 |
| Investissements à court terme | 0 | 0 | 0 | 100 | |
| Total des créances, nettes | 471.7 | 472.7 | 421.3 | 402.6 | 413.8 |
| Accounts Receivable - Trade, Net | 471.7 | 472.7 | 421.3 | 402.6 | 413.8 |
| Total Inventory | 858.8 | 800.1 | 749.5 | 759 | 739.9 |
| Other Current Assets, Total | 204.6 | 194.9 | 239.6 | 202.9 | 181 |
| Total Assets | 3763.9 | 3611.8 | 3336.9 | 3384.8 | 3550.7 |
| Property/Plant/Equipment, Total - Net | 510.9 | 538.2 | 421.5 | 395 | 403.8 |
| Goodwill, Net | 527.3 | 457.6 | 381.5 | 396.2 | 384.3 |
| Intangibles, Net | 298.5 | 270.9 | 214 | 233.5 | 227.5 |
| Other Long Term Assets, Total | 294.2 | 231.9 | 283.3 | 272.6 | 284.3 |
| Total Current Liabilities | 1048.5 | 914.3 | 864.6 | 818.4 | 880.5 |
| Accounts Payable | 196.2 | 178.4 | 157.7 | 154.9 | 161.2 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 120.1 | 18.7 | 17 | 14 | 11 |
| Other Current Liabilities, Total | 732.2 | 717.2 | 689.9 | 649.5 | 708.3 |
| Total Liabilities | 2583.6 | 2498 | 2399.9 | 2414.3 | 2533.7 |
| Total Long Term Debt | 1109 | 1200.5 | 1136.8 | 1171 | 1205.4 |
| Long Term Debt | 1109 | 1200.5 | 1136.8 | 1171 | 1205.4 |
| Minority Interest | 30.5 | 18 | 16.7 | 20.2 | 21.1 |
| Other Liabilities, Total | 395.6 | 302.9 | 381.8 | 404.7 | 426.7 |
| Total Equity | 1180.3 | 1113.8 | 937 | 970.5 | 1017 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Common Stock | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| Treasury Stock - Common | -1107.2 | -1085 | -1058.6 | -986.2 | -925.9 |
| Other Equity, Total | 2285.8 | 14.8 | 1993.9 | 1955 | 1941.2 |
| Total Liabilities & Shareholders’ Equity | 3763.9 | 3611.8 | 3336.9 | 3384.8 | 3550.7 |
| Total Common Shares Outstanding | 146.761 | 147.023 | 147.367 | 148.324 | 149.292 |
| Deferred Income Tax | 62.3 | ||||
| Additional Paid-In Capital | 256.3 | ||||
| Retained Earnings (Accumulated Deficit) | 1926 |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenu net/Ligne de départ | 298.5 | 280.6 | 161.4 | 198 | 181 |
| Liquidités provenant des activités d'exploitation | 274.4 | 282.4 | 332.2 | 213.4 | 239.7 |
| Liquidités provenant des activités d'exploitation | 88.8 | 89.1 | 80.4 | 75.6 | 64.9 |
| Deferred Taxes | -14.8 | -5.8 | -22.5 | -5.4 | -15.1 |
| Éléments non monétaires | 46 | 44.1 | 43.3 | 19.7 | 51.1 |
| Cash Taxes Paid | 147.4 | 145.5 | 43 | 61.3 | 60.5 |
| Intérêts payés en espèces | 24.3 | 19.6 | 28.7 | 16 | 11.7 |
| Variation du fonds de roulement | -144.1 | -125.6 | 69.6 | -74.5 | -42.2 |
| Flux de trésorerie liés aux activités d'investissement | -251.6 | -192.4 | -192.7 | -158.4 | -123.4 |
| Dépenses d'investissement | -129.2 | -92 | -97.2 | -73 | -49.2 |
| Autres éléments de flux de trésorerie d'investissement, total | -122.4 | -100.4 | -95.5 | -85.4 | -74.2 |
| Flux de trésorerie provenant des activités de financement | -415.3 | 318.7 | -161.6 | 300 | -112.4 |
| Éléments de flux de trésorerie de financement | -14.5 | -0.5 | -8.8 | -10.6 | -3.2 |
| Total Cash Dividends Paid | -29.8 | -24.2 | -24.6 | -25 | -25.1 |
| Émission (remboursement) d'actions, nette | -260.3 | -146.3 | -119.9 | -131.4 | 9.4 |
| Émission (remboursement) de la dette, nette | -110.7 | 489.7 | -8.3 | 467 | -93.5 |
| Effets de change | -30.5 | -22.5 | 25.7 | 0.6 | -6.5 |
| Variation nette de la trésorerie | -423 | 386.2 | 3.6 | 355.6 | -2.6 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 77.4 | 298.5 | 200.2 | 111.8 | 62.1 |
| Cash From Operating Activities | 87.5 | 274.4 | 102.9 | 33.4 | 77.8 |
| Cash From Operating Activities | 25.1 | 88.8 | 64.3 | 43.3 | 21.7 |
| Deferred Taxes | 1.2 | -14.8 | -25.7 | -8.2 | -4 |
| Non-Cash Items | 8.6 | 46 | 34.8 | 21.6 | 1.8 |
| Changes in Working Capital | -24.8 | -144.1 | -170.7 | -135.1 | -3.8 |
| Cash From Investing Activities | -108.2 | -251.6 | -102.3 | -44.7 | -101.8 |
| Capital Expenditures | -25 | -129.2 | -94.6 | -36.9 | -19 |
| Other Investing Cash Flow Items, Total | -83.2 | -122.4 | -7.7 | -7.8 | -82.8 |
| Cash From Financing Activities | -30.7 | -415.3 | -379.2 | -297.2 | -217.4 |
| Financing Cash Flow Items | 4.3 | -14.5 | -12.3 | -12.2 | -1.2 |
| Total Cash Dividends Paid | -7.4 | -29.8 | -22.4 | -15 | -7.5 |
| Issuance (Retirement) of Stock, Net | -21.7 | -260.3 | -236 | -162.6 | -102.5 |
| Issuance (Retirement) of Debt, Net | -5.9 | -110.7 | -108.5 | -107.4 | -106.2 |
| Foreign Exchange Effects | 4.1 | -30.5 | -63.8 | -36.9 | -10.7 |
| Net Change in Cash | -47.3 | -423 | -442.4 | -345.4 | -252.1 |
| Nom de l'investisseur | Catégorie de l'investisseur | Pourcentage de l'encours | Actions détenues | Changement d'actions | Date d'avoirs | Taux du chiffre d'affaires |
|---|---|---|---|---|---|---|
| Laukien (Frank H) | Individual Investor | 26.982 | 39589954 | -600000 | 2023-05-16 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 10.0131 | 14691904 | -1676240 | 2023-03-31 | MED |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.574 | 11113147 | 89092 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.6837 | 9806862 | -160344 | 2023-03-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 6.3064 | 9253273 | -393849 | 2023-03-31 | LOW |
| Laukien (Joerg C) | Individual Investor | 5.1223 | 7515769 | 0 | 2022-12-31 | |
| MFS Investment Management | Investment Advisor/Hedge Fund | 4.996 | 7330498 | 61034 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.2552 | 3308939 | 71574 | 2023-03-31 | LOW |
| AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 1.87 | 2743740 | -353226 | 2023-03-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 1.7501 | 2567833 | -382242 | 2023-03-31 | LOW |
| Fuller & Thaler Asset Management Inc. | Investment Advisor/Hedge Fund | 1.536 | 2253694 | 86411 | 2023-03-31 | LOW |
| Pallas Capital Advisors LLC | Investment Advisor | 1.1831 | 1735945 | 0 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.1467 | 1682457 | -8588 | 2023-03-31 | LOW |
| Fidelity Institutional Asset Management | Investment Advisor | 1.0989 | 1612331 | -73588 | 2023-03-31 | LOW |
| Brown Advisory | Investment Advisor/Hedge Fund | 1.0819 | 1587450 | 26251 | 2023-03-31 | LOW |
| TD Asset Management Inc. | Investment Advisor | 0.9476 | 1390353 | -170892 | 2023-03-31 | LOW |
| Citadel Advisors LLC | Hedge Fund | 0.9379 | 1376143 | 978996 | 2023-03-31 | HIGH |
| Alyeska Investment Group, L.P. | Hedge Fund | 0.8949 | 1313065 | 568267 | 2023-03-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.837 | 1228130 | 27256 | 2023-03-31 | LOW |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 0.8092 | 1187342 | 1187342 | 2023-03-31 | LOW |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com Group535K+
Tradeurs
87K+
Clients actifs par mois
$113M+
Volume d'investissement par mois
$64M+
Retrait par mois
Trading calculator
Calculez votre P&L hypothétique si vous aviez ouvert une transaction CFD à une certaine date (sélectionnez une date) et l'aviez fermée à une autre date (sélectionnez une date).
Trade commission
0
- 1:1
Effet de levier
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Ouverture
Clôture
Short Long
Bruker Company profile
À propos de Bruker
Bruker Corporation est un développeur, fabricant et distributeur d'instruments scientifiques et de solutions analytiques et diagnostiques. La société opère à travers quatre segments : Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group et Bruker Energy & Supercon Technologies (BEST). Le segment Bruker BioSpin Group conçoit, fabrique et distribue des outils de sciences de la vie basés sur la technologie de résonance magnétique. Le segment Bruker CALID Group conçoit, fabrique et distribue des solutions de spectrométrie de masse et de spectrométrie de mobilité ionique pour les sciences de la vie, ainsi que des instruments et des solutions d'analyse et de processus. Le segment BSI NANO Group conçoit et fabrique des instruments avancés à rayons X, des instruments avancés de microscopie optique à fluorescence, des outils analytiques pour les microscopes électroniques et la métrologie des rayons X, ainsi que des équipements de détection des défauts. Le segment BEST développe et fabrique des matériaux et des dispositifs supraconducteurs et non supraconducteurs.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
40 Manning Rd
BILLERICA
MASSACHUSETTS 01821-3915
US
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 535 000 traders du monde entier qui ont choisi de trader avec Capital.com